I know nothing, friend, that's just my opinion. The fall and fall of ANR can be attributed to the inability to define an effective pharmacological pathway for bromelain - a well characterised, generic enzyme with limited/low margin capacity. That's an opinion too.
If SUD was in the lipstick game, they should be teaming up with supermodels and superstars. Not pigs.
I know nothing, friend, that's just my opinion. The fall and...
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.005(4.55%) |
Mkt cap ! $126.0M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.0¢ | 11.0¢ | $54.75K | 480.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 221729 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 184658 | 3 |
View Market Depth
| Last trade - 10.48am 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
0.005 ( 2.22 %) |
||||
| Open | High | Low | Volume | ||
| 11.3¢ | 11.5¢ | 11.3¢ | 163434 | ||
| Last updated 10.48am 16/05/2024 ? | |||||
| ALA (ASX) Chart |